Fritextsökning
Innehållstyper
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Första patienterna har testat kräm för hårväxtstimulering
Nu har Follicums fas II-studie med FOL-005-kräm startat på riktigt. De första manliga patienterna med håravfall har nu behandlats.
-
Hey Kurt Berndt...
... who is starting up a research center for youths in Saltsjöbaden.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Double the channels for half the work
The 16-well pipettes from Capp cause less strain for the user when setting up a 384-well plate.
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
A platform for dialogue
As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Astra Zeneca lovar leverans av 2 miljarder vaccindoser mot corona
Totalt har läkemedelsföretaget ingått avtal med flera producenter och lovar nu leverans om totalt 2 miljoner vaccindoser mot det nya coronaviruset.
-
Läste inte det finstilta – miste sitt livsverk
I ena stunden hyllad vd och medgrundare till ett banbrytande labbföretag – i nästa avskedad, utkastad och raderad ur bolagets historia. Här är historien om hur ...
-
Reproducibility and handling in focus with new electronic pipette
The Eppendorf Xplorer electronic pipette has been developed with reproducibility in mind.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Sales Representative, Applied Biosystems
-
Missnöjd med din julklappsslips? Här är våra läsetips
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Many rotor options for refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Will the industry follow the economic revival?
Welcome to the eleventh Biotech Forum + Scanlab Fair!
-
Globalt uttalande
Pfizers globala uttalande efter patentgodkännande av Prevenar 13 i Indien.
-
Multiple rotor options in refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Påstående om höjd livskvalitet bedöms som regelbrott
Att ett preparat lindrar smärtan är inte detsamma som att det ger livskvaliteten tillbaka. Nu fälls en annons för Voltaren av IGN för att inte följa branschens etiska regler.